# US 2010/0167361 A1 · Non-revertible beta-oxidation blocked candida tropicalis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167361 A1
- Document ID: US20100167361A1
- Status: Published application
- Kind: A1
- Application number: 12/244,677
- Filed: 2008-10-02
- Published: 2010-07-01
- Earliest claimed: 2002-05-23
- Assignees: Cognis Corporation
- Inventors: David L. Craft
- Web page: https://patentgrep.com/patent/US20100167361A1

## CPC

- C12N 1/165: Yeast isolates
- C12P 7/44: Polycarboxylic acids
- C12R 2001/74: Candida tropicalis
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

Genetically modified strains of C. tropicalis, which will not revert to wild-type activity at the POX 4 and/or POX 5 locus, are disclosed. The strains are β-oxidation blocked and have been transformed through homologous recombination with a construct which deletes a portion of the POX 4 and/or POX 5 gene. The modified strains may be used to increase yields of dicarboxylic acids produced in host cells of the strains. Methods for blocking the β-oxidation pathway in a C. tropicalis host cell are also provided.

## Claims

### Claim 1

A Candida tropicalis cell having a disrupted chromosomal POX 4 gene wherein a portion of said POX 4 gene has been deleted through homologous recombination with a DNA fragment comprising a selectable marker gene, wherein said selectable marker gene is flanked on both ends by DNA sequences having homology to non-contiguous portions of said POX 4 gene and wherein the presence of the deleted portion of the POX 4 gene prevents recombination to a functional POX 4 gene.

### Claim 2 (depends on 1)

The Candida tropicalis cell of claim 1 wherein the POX 4 gene is POX 4A.

### Claim 3 (depends on 1)

The Candida tropicalis cell of claim 1 wherein the POX 4 gene is POX 4B.

### Claim 4 (depends on 1)

The Candida tropicalis cell of claim 1 wherein the POX 4 gene comprises both POX 4A and POX 4B.

### Claim 5 (depends on 1)

The Candida tropicalis cell of claim 1 wherein the DNA fragment comprises a URA 3 selectable marker gene.

### Claim 6 (depends on 1)

The Candida tropicalis cell of claim 1 comprising the strain H53.

### Claim 7 (depends on 1)

A process for producing a substantially pure α,ω-dicarboxylic acid which comprises culturing the Candida tropicalis cell of claim 1 in a culture medium containing a nitrogen source, an organic substrate and a cosubstrate.

### Claim 8

A Candida tropicalis cell having a disrupted chromosomal POX 5 gene wherein a portion of said POX 5 gene has been deleted through homologous recombination with a DNA fragment comprising a selectable marker gene, wherein said selectable marker gene is flanked on both ends by DNA sequences having homology to non-contiguous portions of said POX 5 gene and wherein the presence of the deleted portion of the POX 5 gene prevents recombination to a functional POX 4 gene.

### Claim 9 (depends on 8)

The Candida tropicalis cell of claim 8 comprising both copies of a chromosomal POX 5 gene.

### Claim 10 (depends on 8)

The Candida tropicalis cell of claim 8 wherein the DNA fragment comprises a URA 3 selectable marker gene.

### Claim 11 (depends on 8)

The Candida tropicalis cell of claim 8 comprising the strain H53.

### Claim 12 (depends on 8)

A process for producing a substantially pure α,ω-dicarboxylic acid comprising culturing the Candida tropicalis cell of claim 8 in a culture medium containing a nitrogen source, an organic substrate and a cosubstrate.

### Claim 13

A Candida tropicalis cell having disrupted chromosomal POX 4 and POX 5 genes wherein a portion of both of said POX 4 and POX 5 genes has been deleted through homologous recombination with a DNA fragment comprising a selectable marker gene wherein said selectable marker gene is flanked on both ends by DNA sequences having homology to non-contiguous portions of both of said POX 4 and POX 5 genes and wherein the presence of the deleted portions of both of the POX 4 and POX 5 genes prevent recombination to functional POX 4 and POX 5 genes.

### Claim 14 (depends on 13)

The Candida tropicalis cell of claim 13 wherein the POX 4 gene is POX 4A.

### Claim 15 (depends on 13)

The Candida tropicalis cell of claim 13 wherein the POX 4 gene is POX 4B.

### Claim 16 (depends on 13)

The Candida tropicalis cell of claim 13 wherein the POX 4 gene comprises both POX 4A and POX 4B.

### Claim 17 (depends on 13)

The Candida tropicalis cell of claim 13 comprising both copies of a chromosomal POX 5 gene.

### Claim 18 (depends on 13)

The Candida tropicalis cell of claim 13 wherein the DNA fragment comprises a URA 3 selectable marker gene.

### Claim 19 (depends on 13)

The Candida tropicalis cell of claim 13 comprising the strain H53.

### Claim 20 (depends on 17)

The Candida tropicalis cell of claim 17 wherein the POX 4 gene is POX 4A.

### Claim 21 (depends on 17)

The Candida tropicalis cell of claim 17 wherein the POX 4 gene is POX 4B.

### Claim 22 (depends on 17)

The Candida tropicalis cell of claim 17 wherein the POX 4 gene is both POX 4A and POX 4B.

### Claim 23 (depends on 13)

A process for producing a substantially pure α,ω-dicarboxylic acid which comprises culturing the Candida tropicalis cell of claim 13 in a culture medium containing a nitrogen source, an organic substrate and a cosubstrate.

### Claim 24

A process for completely blocking the β-oxidation pathway in a Candida tropicalis host cell which comprises disrupting through homologous recombination a portion of a POX 4 gene with a DNA fragment comprising a selectable marker gene wherein said selectable marker gene is flanked on both ends by DNA sequences having homology to non-contiguous portions of said POX 4 gene and wherein the presence of the deleted portion of the POX 4 gene prevents recombination to a functional POX 4 gene.

### Claim 25 (depends on 24)

The process of claim 24 wherein the POX 4 gene is POX 4A.

### Claim 26 (depends on 24)

The process of claim 24 wherein the POX 4 gene is POX 4B.

### Claim 27 (depends on 24)

The process of claim 24 wherein the POX 4 gene comprises both POX 4A and POX 4B.

### Claim 28 (depends on 24)

The process of claim 24 wherein the DNA fragment comprises a URA 3 selectable marker gene.

### Claim 29 (depends on 24)

The process of claim 24 wherein the Candida tropicalis host cell comprises strain H53.

### Claim 30

A process for completely blocking the β-oxidation pathway in a Candida tropicalis host cell which comprises disrupting through homologous recombination a portion of a POX5 gene with a DNA fragment comprising a selectable marker gene wherein said selectable marker gene is flanked on both ends by DNA sequences having homology to non-contiguous parts of said POX 5 gene and wherein the presence of the deleted portion of the POX 5 gene prevents recombination to a functional POX 5 gene.

### Claim 31 (depends on 30)

The process of claim 30 wherein the host cell comprises both copies of a chromosomal POX 5 gene.

### Claim 32 (depends on 30)

The process of claim 30 wherein the DNA fragment comprises a URA 3 selectable marker gene.

### Claim 33 (depends on 30)

The process of claim 30 wherein the Candida tropicalis host cell comprises strain H53.

### Claim 34

A process for completely blocking the β-oxidation pathway in a Candida tropicalis host cell which comprises disrupting through homologous recombination a portion of both of POX 4 and POX 5 genes with a DNA fragment comprised of a selectable marker gene wherein said selectable marker gene is flanked on both ends by DNA sequences having homology to non-contiguous portions of both of said POX 4 and POX 5 genes and wherein the deleted portions of both of the POX 4 and POX 5 genes prevent recombination to functional POX 4 and POX 5 genes.

### Claim 35 (depends on 34)

The process of claim 34 wherein the POX 4 gene is POX 424.

### Claim 36 (depends on 34)

The process of claim 34 wherein the POX 4 gene is POX 4B.

### Claim 37 (depends on 34)

The process of claim 34 wherein the POX 4 gene comprises both POX 4A and POX 4B.

### Claim 38 (depends on 34)

The process of claim 34 wherein the host cell comprises both copies of the chromosomal POX 5 gene.

### Claim 39 (depends on 34)

The process of claim 34 wherein the DNA fragment comprises a URA 3 selectable marker gene.

### Claim 40 (depends on 34)

The process of claim 34 wherein the Candida tropicalis host cell comprises strain H53.

### Claim 41 (depends on 38)

The process of claim 38 wherein the POX 4 gene is POX 4A.

### Claim 42 (depends on 38)

The process of claim 38 wherein the POX 4 gene is POX 4B.

### Claim 43 (depends on 38)

The process of claim 38 wherein the POX 4 gene comprises both POX 4A and POX 4B.
